中华医学遗传学杂志
中華醫學遺傳學雜誌
중화의학유전학잡지
CHINESE JOURNAL OF MEDICAL GENETICS
2010年
1期
23-28
,共6页
肖涵%汤建光%胡治平%谭洁琼%唐北沙%蒋正
肖涵%湯建光%鬍治平%譚潔瓊%唐北沙%蔣正
초함%탕건광%호치평%담길경%당북사%장정
ataxin-3%自吞噬途径%降解
ataxin-3%自吞噬途徑%降解
ataxin-3%자탄서도경%강해
ataxin-3%autophagy%degradation
目的 探讨自吞噬途径(autophagy)在脊髓小脑型共济失调3型或称马查多-约瑟夫病(spinocerebellar ataxia 3/Machado-Joseph disease,SCA3/MJD)发病机制中的作用.方法 将CAG拷贝数68次的ataxin-3真核表达载体pcDNA3.1-Myc-His(B)-MJD68Q在HEK293细胞中表达,采用特异性自吞噬途径抑制剂及激活剂处理细胞后,检测细胞中ataxin-3-68Q的表达水平.结果 抑制自吞噬途径水平,细胞内ataxin-3-68Q表达明显增加,细胞活性降低;反之亦然.结论 自吞噬途径参与降解细胞内多聚谷氨酰胺扩展突变型ataxin-3,减少胞内聚合物的形成,从而减轻细胞毒性.因此,提高机体自吞噬途径水平有望作为治疗SCA3/MJD的新方法 .
目的 探討自吞噬途徑(autophagy)在脊髓小腦型共濟失調3型或稱馬查多-約瑟伕病(spinocerebellar ataxia 3/Machado-Joseph disease,SCA3/MJD)髮病機製中的作用.方法 將CAG拷貝數68次的ataxin-3真覈錶達載體pcDNA3.1-Myc-His(B)-MJD68Q在HEK293細胞中錶達,採用特異性自吞噬途徑抑製劑及激活劑處理細胞後,檢測細胞中ataxin-3-68Q的錶達水平.結果 抑製自吞噬途徑水平,細胞內ataxin-3-68Q錶達明顯增加,細胞活性降低;反之亦然.結論 自吞噬途徑參與降解細胞內多聚穀氨酰胺擴展突變型ataxin-3,減少胞內聚閤物的形成,從而減輕細胞毒性.因此,提高機體自吞噬途徑水平有望作為治療SCA3/MJD的新方法 .
목적 탐토자탄서도경(autophagy)재척수소뇌형공제실조3형혹칭마사다-약슬부병(spinocerebellar ataxia 3/Machado-Joseph disease,SCA3/MJD)발병궤제중적작용.방법 장CAG고패수68차적ataxin-3진핵표체재체pcDNA3.1-Myc-His(B)-MJD68Q재HEK293세포중표체,채용특이성자탄서도경억제제급격활제처리세포후,검측세포중ataxin-3-68Q적표체수평.결과 억제자탄서도경수평,세포내ataxin-3-68Q표체명현증가,세포활성강저;반지역연.결론 자탄서도경삼여강해세포내다취곡안선알확전돌변형ataxin-3,감소포내취합물적형성,종이감경세포독성.인차,제고궤체자탄서도경수평유망작위치료SCA3/MJD적신방법 .
Objective To investigate the role of autophagy on the pathogenesis of spinocerebellar ataxia 3/Machado-Joseph disease (SCA3/MJD). Methods HEK293 cells expressing polyglutamineexpanded ataxin-3 were used as cell model for SCA3/MJD. The level of polyglutamine-expanded ataxin-3was detected after cells were treated with different inhibitors or inducer of autophagy. Results Inhibition of autophagy increased aggregate formation and cell death in HEK293 cells expressing mutated ataxin-3, and vice versa. Conclusion The data suggested that autophagy is involved in the degradation of mutant ataxin3, resulting in a decrease in the proportions of aggregate-containing cells and cell death in HEK293 cells expressing polyglutamine-expanded ataxin-3. It is possible that autophagy may be applied as a potential therapeutic approach for SCA3/MJD.